Secondary GBM derives from a malignant progression of diffuse or anaplastic astrocytomas (grade-II and -III, respectively), and occurs in younger patients, characterized by p53 mutation and a reduced state of heterozygosity in tumor cells (loss of heterozygosity) on chromosome 10q (32). This evidence concerns the gene TP53 and glioblastoma.